Which of the following causes teratogenicity?
Which one of the following antibiotic is not recommended for lactating mothers?
Ichthyosis is a side effect of -
Drug that is contraindicated in renal failure is:
Nowadays radium is not used in the Rx of cancer because:
Which Benzodiazepine decreases post-operative nausea & vomiting:-
Pseudotumor Cerebri in Infants is seen with?
Which one of the following increases the potassium level in the body –
Renal stones are seen as a complication by using the following drug:
Which of these drugs can be a cause of rhabdomyolysis?
Explanation: ***Vitamin A*** - Excessive intake of **Vitamin A (retinoids)**, particularly during early pregnancy, is a known cause of **teratogenicity**. - It can lead to various birth defects, including **craniofacial abnormalities**, **cardiac defects**, and **central nervous system malformations**. *Vitamin E* - **Vitamin E** is generally considered safe during pregnancy and has no known teratogenic effects at recommended dosages. - It functions as an **antioxidant** and is important for cell protection. *Vitamin D* - While **Vitamin D** is essential for proper fetal development, excessive intake is not typically associated with teratogenicity but can cause **hypercalcemia** in the mother and fetus. - Mild to moderate supplementation is often recommended during pregnancy for bone health. *Vitamin C* - **Vitamin C** is a water-soluble vitamin and is not considered teratogenic, even at higher doses, as excess amounts are readily excreted. - It plays a crucial role in **collagen synthesis** and immune function during pregnancy.
Explanation: ***Quinolones*** - **Quinolones** are generally **not recommended** for lactating mothers due to concerns about potential harm to the infant's developing **cartilage** and **joints**. - They have been associated with **arthropathies** and **tendinopathies** in animal studies and young patients, leading to caution in this population. *Aminoglycoside* - **Aminoglycosides** are typically considered **safe** in lactation because they have **poor oral absorption** by the infant, meaning very little drug reaches the infant's systemic circulation. - While they can be excreted into breast milk, the amount absorbed by the infant is usually **negligible**, reducing risk of toxicity. *Cephalosporins* - **Cephalosporins** are generally considered **safe** for lactating mothers as they are excreted into breast milk in **low concentrations** and have a good safety profile for infants. - Potential side effects in the infant are usually minor, such as **diarrhea** or **thrush**, and serious adverse events are rare. *Anti tubercular drugs* - Most **first-line anti-tubercular drugs** (e.g., isoniazid, rifampicin, ethambutol, pyrazinamide) are generally **considered compatible** with breastfeeding. - While they do pass into breast milk, the benefits of treating **maternal tuberculosis** and preventing transmission to the infant usually outweigh the theoretical risks.
Explanation: ***Clofazamine*** - **Clofazimine** is an antimycobacterial drug used to treat **leprosy**, and one of its characteristic skin-related side effects is **ichthyosis**, presenting as dry, scaly skin. - It accumulates in fatty tissues and the reticuloendothelial system, causing a range of skin pigmentation changes from red-brown to black, often associated with generalized dryness and scaling. *Capreomycin* - **Capreomycin** is an injectable antibiotic primarily used for **multi-drug resistant tuberculosis (MDR-TB)**. - Its main side effects involve **nephrotoxicity** and **ototoxicity**, not ichthyosis. *Letrozole* - **Letrozole** is an **aromatase inhibitor** used in the treatment of **hormone-receptor-positive breast cancer** in postmenopausal women. - Common side effects include **hot flashes**, **arthralgia**, and **fatigue**, but not ichthyosis. *Cephalosporin* - **Cephalosporins** are a class of **beta-lactam antibiotics** widely used for bacterial infections. - While they can cause various side effects like **allergic reactions** (rash, anaphylaxis), **gastrointestinal upset**, and **nephrotoxicity** at high doses, ichthyosis is not a recognized side effect.
Explanation: ***Streptomycin*** - **Streptomycin** is primarily cleared renally, and its accumulation in **renal failure** can lead to significant **ototoxicity** and **nephrotoxicity**. - Its use in patients with compromised kidney function is contraindicated or requires significant dose reduction and careful monitoring. *Isoniazid* - **Isoniazid** is metabolized mainly by the liver, and only a small portion is excreted unchanged by the kidneys, making it relatively safe in **renal failure** with slight dose adjustments. - While it can cause **hepatotoxicity**, its renal excretion is not a primary concern. *Ethambutol* - Although **Ethambutol** is primarily eliminated renally, its dose can be adjusted in **renal failure** to prevent toxicity, most notably **optic neuritis**. - It is not outright contraindicated, but careful monitoring of renal function and visual acuity is necessary. *Rifampicin* - **Rifampicin** is extensively metabolized by the liver and is largely excreted through bile and feces, with only a small fraction excreted renally. - Therefore, it can be used safely in patients with **renal failure** without significant dose adjustment.
Explanation: ***It decays into daughter Radon which is a constant hazard*** - Radium-226 decays into **Radon-222**, a radioactive gas that can leak from sealed sources or medical devices. - This **gaseous daughter product** poses a significant radiation hazard to patients and medical staff, necessitating extensive safety precautions. *It is a very unstable element* - While radium is a **radioactive element** and thus unstable, its inherent instability alone isn't the primary reason for its disuse in cancer therapy. - The specific hazard comes from **what it decays into**, not just the act of decay itself. *It decays faster and needs frequent replacement* - Radium-226 has a **half-life of 1600 years**, meaning it decays very slowly and would not require frequent replacement. - This long half-life is actually a characteristic that makes its daughter product, Radon-222, a persistent issue rather than a rapid decay being the problem. *It has a very long half life* - A long half-life (e.g., 1600 years for Radium-226) means the radioactive material persists for a very long time, leading to a **prolonged source of radiation**. - While this is true, the primary concern in its historical therapeutic use was the **radioactive gaseous daughter product**, Radon, which accumulates and poses an ongoing hazard.
Explanation: ***Midazolam*** - **Midazolam** is a commonly used benzodiazepine in anesthesia that has been shown to have **antiemetic properties** and can decrease the incidence of **postoperative nausea and vomiting (PONV)**. - Its mechanism may involve its sedative and anxiolytic effects, indirectly reducing the triggers for nausea. *Diazepam* - While **diazepam** is a benzodiazepine with sedative and anxiolytic effects, it is not primarily known for reducing PONV. - Its longer duration of action compared to midazolam can also contribute to unwanted **postoperative sedation**. *Lorazepam* - **Lorazepam** is another benzodiazepine used for anxiolysis and sedation but is not a primary agent for the prevention of PONV. - Like diazepam, its prolonged effects can lead to **delayed recovery** and drowsiness, which may not be desirable in the postoperative period. *All of the options* - While all listed drugs are benzodiazepines, only **midazolam** is consistently recognized and utilized for its ability to reduce PONV in the perioperative setting. - The other benzodiazepines do not demonstrate the same consistent benefit in PONV reduction and may have other side effects that limit their utility for this specific purpose.
Explanation: ***Tetracyclines***- **Tetracyclines**, particularly in infants, are a known cause of **pseudotumor cerebri**, also known as **idiopathic intracranial hypertension (IIH)**. - This condition involves increased **intracranial pressure (ICP)**, leading to symptoms like **headache**, **visual disturbances**, and **papilledema**. *Aminoglycosides*- **Aminoglycosides** are primarily associated with **ototoxicity** (hearing loss) and **nephrotoxicity** (kidney damage) [1]. - They are not typically linked to the development of **pseudotumor cerebri**. *NSAIDS*- **NSAIDs** (Nonsteroidal Anti-inflammatory Drugs) are more commonly associated with **gastrointestinal ulcers** and **renal impairment**. - While they can have neurological side effects in some cases, **pseudotumor cerebri** is not a characteristic or common adverse effect. *Macrolides*- **Macrolides** like erythromycin or azithromycin are generally well-tolerated and are primarily associated with **gastrointestinal upset** and **QT prolongation**. - There is no significant evidence linking **macrolide use** to the development of **pseudotumor cerebri**.
Explanation: ***Suxamethonium*** - **Suxamethonium** (succinylcholine) is a depolarizing neuromuscular blocker that causes a transient, dose-dependent release of potassium from muscle cells, leading to a rise in serum potassium levels. - This effect is due to its action on **nicotinic acetylcholine receptors**, which causes prolonged depolarization and opening of ion channels, allowing potassium to efflux from the cells. *Pancuronium* - **Pancuronium** is a non-depolarizing neuromuscular blocker that acts by competitively binding to nicotinic acetylcholine receptors without causing depolarization. - It does not cause a significant release of potassium from muscle cells and is not associated with hyperkalemia. *E–tubocurarine* - **Tubocurarine** is a non-depolarizing neuromuscular blocker that works by competing with acetylcholine for binding to nicotinic receptors at the neuromuscular junction. - It does not directly cause potassium release from cells and is not associated with an increase in serum potassium levels. *Gallamine* - **Gallamine** is a non-depolarizing neuromuscular blocker with a similar mechanism of action to pancuronium and tubocurarine. - It works by competitively antagonizing acetylcholine at the neuromuscular junction and does not cause clinically significant hyperkalemia.
Explanation: ***Zonisamide*** - **Zonisamide** is a sulfonamide derivative that can inhibit **carbonic anhydrase**, leading to metabolic acidosis and increased urinary calcium excretion, which promotes the formation of **kidney stones**. - Patients on zonisamide should be monitored for **renal stone formation** and advised to maintain adequate hydration. *Oxcarbazepine* - **Oxcarbazepine** is an antiepileptic drug known for causing **hyponatremia** and, less commonly, dermatological reactions such as rash. - It is not typically associated with a significant risk of **renal stone formation**. *Phenytoin* - **Phenytoin** is an older antiepileptic drug commonly associated with side effects such as **gingival hyperplasia**, hirsutism, and folate deficiency. - While it has various side effects, **nephrolithiasis** (kidney stones) is not a common or recognized complication. *Tiagabine* - **Tiagabine** is an antiepileptic drug that works by inhibiting GABA reuptake. Its main side effects include dizziness, weakness, and somnolence. - There is no significant evidence to suggest that **tiagabine** causes **renal stone formation**.
Explanation: ***All of these*** - **Statins**, **salicylates**, and **antidepressants** (especially selective serotonin reuptake inhibitors or tricyclic antidepressants in overdose) have all been linked to cases of rhabdomyolysis. - The risk of rhabdomyolysis can increase significantly in the presence of **polypharmacy**, certain genetic predispositions, or concurrent medical conditions. **Statins (HMG-CoA reductase inhibitors)** - Well-known for their potential to cause **myopathy** and, in more severe cases, **rhabdomyolysis**, due to their effects on muscle cell integrity. - The risk is **dose-dependent** and can be exacerbated by interactions with other drugs that inhibit statin metabolism (e.g., fibrates, azole antifungals, macrolides). - Most commonly reported drug class associated with rhabdomyolysis. **Antidepressants** - Certain **antidepressants**, particularly in overdose or when combined with other serotonergic agents (leading to **serotonin syndrome**), can induce rhabdomyolysis. - **Tricyclic antidepressants (TCAs)** and **selective serotonin reuptake inhibitors (SSRIs)** have been implicated, either directly or indirectly through complications like seizures or hyperthermia. - Risk is higher in overdose situations or with drug-drug interactions. **Salicylates** - **Salicylates**, especially in cases of **acute or chronic toxicity** (e.g., **aspirin overdose**), can directly cause muscle damage leading to rhabdomyolysis. - Mechanisms involved may include uncoupling of oxidative phosphorylation, leading to **hyperthermia** and direct cellular toxicity within muscle tissue. - Less common than statins but well-documented in toxicity cases.
Principles of Clinical Pharmacology
Practice Questions
Therapeutic Drug Monitoring
Practice Questions
Drug Toxicity and Overdose
Practice Questions
Antidotes and Their Applications
Practice Questions
Management of Drug Poisoning
Practice Questions
Drug-Induced Liver Injury
Practice Questions
Drug-Induced Kidney Injury
Practice Questions
Drug-Induced Blood Dyscrasias
Practice Questions
Drug-Induced QT Prolongation
Practice Questions
Pharmacovigilance
Practice Questions
Get full access to all questions, explanations, and performance tracking.
Start For Free